V. Margaret Jackson

机构：University of Liverpool, Pfizer (United States), Liverpool Heart and Chest Hospital · ORCID：0000-0002-0079-3915

发表论文 43 篇 · 总被引 999 次 · h-index 18

代表论文

• A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor (2022 · Journal of Medicinal Chemistry · 被引 167)
• Latest approaches for the treatment of obesity (2015 · Expert Opinion on Drug Discovery · 被引 130)
• Augmented capacity for peripheral serotonin release in human obesity (2018 · International Journal of Obesity · 被引 84)
• Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate (2014 · ACS Medicinal Chemistry Letters · 被引 71)
• Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes (2013 · Diabetes · 被引 68)
• Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects (2016 · British Journal of Clinical Pharmacology · 被引 58)